Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Shionogi & Co ( (JP:4507) ).
Shionogi & Co., Ltd. has announced new management policies aimed at enhancing their awareness of capital costs and stock prices, following a Board of Directors meeting. This strategic move is expected to influence the company’s operational focus and potentially impact its market positioning and stakeholder interests.
The most recent analyst rating on (JP:4507) stock is a Buy with a Yen2770.00 price target. To see the full list of analyst forecasts on Shionogi & Co stock, see the JP:4507 Stock Forecast page.
More about Shionogi & Co
Shionogi & Co., Ltd. is a pharmaceutical company based in Osaka, Japan, known for its focus on developing and marketing pharmaceutical products. The company is engaged in research and development, manufacturing, and distribution of medications, with a strong emphasis on addressing healthcare needs through innovative solutions.
YTD Price Performance: 13.08%
Average Trading Volume: 2,301,334
Technical Sentiment Signal: Buy
Current Market Cap: Yen2148.7B
For an in-depth examination of 4507 stock, go to TipRanks’ Overview page.